Please assess the completion status of the following clinical trial:

Trial Title: Role of Natriuretic Peptides in the Treatment of Acutely Decompensated Heart Failure Patient With Obstructive Airways Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Males and females~2. Over 18 years of age~3. Confirmed written informed consent.~4. Acute decompensated heart failure based on physicians assessment and requiring treatment as per standard emergency department protocols for this condition.~5. Requirement for intravenous therapy of HF, e.g. diuretic, vasodilator.~6. COAD based on physician's assessment and requiring treatment as per standard emergency department protocols for this condition. Must have at least 2 of the following criteria:~   * history of smoking \> 20 pack years,~  * prior history of PFTs within last 1 year consistent with COAD,~  * history of chronic cough and sputum production,~  * progressive dyspnea, episodes of acute bronchitis over at least 2 yrs~Exclusion Criteria:~1. Women lactating, pregnant or of childbearing potential not using 2 reliable contraceptive methods.~2. Patients who had received an investigational new drug within the last 4 weeks.~3. Patients with a history of a psychological illness or condition such as to interfere with the patient's ability to understand the requirements of the study.~4. SBP \<90mmHg~5. Creatinine \>0.25mmol/L~6. Sp02 \< 80% on supplemental oxygen or known cor pulmonale with TR

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- A (Type: EXPERIMENTAL): Nesiritide
- B (Type: PLACEBO_COMPARATOR): Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).